Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? - Mocroft, A; Touloumi, G; Sighem, A; Abgrall, S; Dray‐Spira, R; Spire, B; Castagna, A; Mussini, C; Zangerle, R; Hessamfar, M; Anderson, J; Ehren, K; et al. (HIV medicine, 2018)
Keywords: Adolescent; Adult; Aged; Anti-Retroviral Agents - therapeutic use; Antiretroviral agents; Antiretroviral drugs; Antiretroviral therapy; Antiretroviral Therapy, Highly Active; CD4 antigen; CD4 Lymphocyte Count; Cohort Studies; Collaboration; combination antiretroviral therapy; Confidence intervals; Epidemiology; Europe; Female; HIV; HIV Infections - drug therapy; Human immunodeficiency virus; Humans; Immunology; immunovirological response; Male; Men; Middle Aged; Migrants; Population Groups; Ribonucleic acid; RNA; RNA, Viral - blood; sex; Sexually transmitted diseases; STD; Transients and Migrants; Treatment Outcome; Viral Load; Women; Young Adult; Western Europe; immunovirological response; HIV; combination antiretroviral therapy; migrants; sex